ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Return on equity (%)

Alfresa Holdings Corporation (2784)

Market cap
¥475.4B
P/E ratio
12.6x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Mar 31, 20255.7-6.71%
Mar 31, 20246.1+13.78%
Mar 31, 20235.4-19.85%
Mar 31, 20226.7+31.89%
Mar 31, 20215.1-42.21%
Mar 31, 20208.8-7.57%
Mar 31, 20199.5+10.45%
Mar 31, 20188.6+5.51%
Mar 31, 20178.2-16.65%
Mar 31, 20169.8+40.86%
Mar 31, 20157

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat